Stay updated on Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a newer version of the page. This change does not modify the study details or other visible content.
    Difference
    0.1%
    Check dated 2026-08-29T18:41:21.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a newer version of the study record page was published.
    Difference
    0.1%
    Check dated 2026-08-08T09:14:38.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a platform update; there are no visible changes to the study information.
    Difference
    0.1%
    Check dated 2026-07-25T00:20:23.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page’s revision tag changed from v3.6.2 to v3.6.3, indicating a new version of the page content. This update does not modify study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-03T14:11:37.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the study record. No study content or criteria appear to have changed as a result.
    Difference
    0.1%
    Check dated 2026-06-26T12:39:13.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate no participants are being sought, and new help/navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header was standardized (instead of 'Intervention / Treatment') and the revision stamp updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T04:24:16.000Z thumbnail image

Stay in the know with updates to Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.